Cervical Cancer Screening Pilot Project

Current project

HopeScan Cervical Cancer Screening Pilot Project

Expanding access to cervical cancer education, screening and treatment for women in Osogbo, Osun State, Nigeria who are often underserved

About the project

HopeScan Initiative is working alongside leading clinical and local healthcare partners in Osogbo, Osun State, Nigeria to expand access to cervical cancer education, screening and treatment for women who are often underserved.

Cervical cancer is the second most common cancer among women in Nigeria, yet screening coverage remains alarmingly low (<5%). The pilot will screen 1,000 women ages 25 to 49 in Osogbo and the surrounding communities using high-sensitivity HPV DNA genotyping, and will connect every woman with an abnormal result to diagnosis and treatment.

End-to-end care costs $35 per patient. The project goal is $35,000.

Aerial view of Osogbo, Osun State, Nigeria

Osogbo, Osun State, Nigeria

Why Osogbo

Osogbo is a growing city in southwestern Nigeria and home to many women who face limited access to cervical cancer screening and preventive healthcare services.

$35per patient, end-to-end care
$35,000project goal
1,000women to be screened
25 to 49ages of women served

Donate to this project

Project initiatives

  • Awareness and educational campaigns
  • Early detection screening for 1,000 patients, with free HPV vaccination for teen girls
  • Diagnostic colposcopy and care for all abnormal and at-risk patients
  • Post-treatment monitoring and wellness support

Clinical partnerships

Dr. Kayode Olusegun Ajenifuja, MBBS, FWACS, FMCOG, MPH

Professor of Obstetrics, Gynaecology and Perinatology

President, Gynecological Oncology Society of Nigeria (GOSON)

Dr. Clement Akinfolarin Adepiti, MBChB, FWACS, FMCOG

Consultant Gynaeoncologist, Department of Obstetrics, Gynaecology and Perinatology

Both partners are based in the Department of Obstetrics, Gynaecology and Perinatology at Obafemi Awolowo University Teaching Hospital (OAUTH), Ile-Ife, Osun State.

What the pilot will show

Data from the pilot will be used to:

  • Prove efficacy. Show that community-anchored HPV DNA screening detects cervical disease early and moves women into treatment.
  • Exceed local care baselines. Measure the pilot’s screening and follow-up results against the care women in Osogbo can reach today.
  • Demonstrate scalability. Document the cost and the process at $35 per patient so the model can be repeated in other communities.

HopeScan is also developing a patient navigation tool that will keep each woman connected to follow-up care from screening through diagnosis and treatment.

Every $35 funds one woman’s screening, diagnosis and follow-up care.

Help us reach the $35,000 goal for 1,000 women in Osogbo.

Donate to this project

See all programs and projects